MONDOBIOTECH
Mondobiotech is a Swiss research company and was focused on finding treatments for rare and neglected diseases. The company partners with relevant communities or parties who are interested in reaching solutions for specific rare diseases. We obtain effective and safe medicinal products candidates (“MPC”) through redirecting existing and known substances into new therapeutic indications. Thus we analyze peptides and other biological immunomodulating substances that are naturally occurring ... in the human body in order to identify promising candidates for the development of medicinal products for use in the treatment of rare and neglected diseases. Our Search & Match engine has so far discovered more then 300 MPC’s for further exploration in as many as possible of the 7’000 rare and neglected diseases. We then seek to license or sell our MPC’s to third parties (such as pharmaceutical or biotechnology companies) and/or to collaborate with third parties to obtain market authorizations and to commercialize such candidates.
MONDOBIOTECH
Industry:
Biotechnology Communities Health Care Medical
Founded:
2001-03-01
Address:
Basel, Basel-Stadt, Switzerland
Country:
Switzerland
Website Url:
http://www.mondobiotech.wiki
Total Employee:
51+
Status:
Closed
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API WordPress Font Awesome Sitelinks Search Box Euro Yoast WordPress SEO Plugin Yoast SEO Premium Yoast Plugins
Similar Organizations
Dermavant Sciences
Dermavant Sciences is a biotechnology company focused on dermatology.
Enzyvant Sciences
Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.
MitMe
biotech company focused on mitochondrial health
Neuronax
NEURONAX is a privately-held biotech company focusing on the development.
Proteros
Proteros is a biotech company focused on enabling lead discovery for challenging targets.
Retro-Tech GmbH
Retro-Tech is a biotech company focusing on services and products.
Silk Road Therapeutics
Clinical stage biotech company focused on rare diseases
Founder
Stock Details
Official Site Inspections
http://www.mondobiotech.wiki
Unable to get host informations!!!
More informations about "mondoBIOTECH"
mondoBIOTECH - Crunchbase Company Profile & Funding
Mondobiotech is a Swiss research company and was focused on finding treatments for rare and neglected diseases. The company partners with relevant communities or parties who are …See details»
mondoBIOTECH AG - Basel, Switzerland - bionity.com
MondoBIOTECH AG, a biotech company, develops healthcare solutions for people with rare and neglected diseases. It offers peptides to companies, foundations, and private persons who are …See details»
Fabio Cavalli - Co-Founder and CEO ad interim
Mondobiotech.wiki — mondoBIOTECH holding AG (SIX:RARE): Executive Chairman and Founder Fabio Cavalli to present at the 4th Berlin Conference …See details»
Mondobiotech Holding AG - Life-Sciences-Europe.com
Jan 1, 2001 · mondoBIOTECH holding AG (SIX Swiss Exchange ticker symbol: RARE), an independent Swiss biotech company, discovers drugs for patients suffering from rare diseases …See details»
Dorian Bevec - Wikipedia
Dorian Bevec is a German molecular biologist, Chief Scientific Officer and co-founder at Mondobiotech. [1] He was born on May 21, 1957, in Zagreb, FPR Yugoslavia.See details»
mondoBIOTECH - Updates, News, Events, Signals & Triggers
May 25, 2011 · mondobiotech.wiki — mondoBIOTECH holding AG (SIX:RARE): United States FDA grants mondoBIOTECH’s Medicinal Product Candidate DasKloster0210 the Orphan Drug …See details»
Mondobiotech — Wikipedia Republished // WIKI 2
Mondobiotech is a Swiss-based biotechnology company focused on developing human peptides as medicaments for patients affected by rare diseases.See details»
mondoBIOTECH: The Swiss biotech BOUTIQUE - ResearchGate
Feb 5, 2008 · Founded 2001, in the year of deciphering of the human genome, mondoBIOTECH is a private company focusing on development of new treatment options for severe and rare …See details»
Orphanet: mondoBIOTECH Laboratories AG
Mondobiotech Laboratories AG. Herrengasse 21. FL-9490 VADUZ . LIECHTENSTEIN. Phone 1: 41 840 200 030 Contact email: [email protected]. Institution's website EUGT Number: …See details»
mondoBIOTECH - Products, Competitors, Financials, Employees ...
Provider of therapeutic concepts for rare and fatal lung diseases. Use the CB Insights Platform to explore mondoBIOTECH's full profile.See details»
Mondobiotech holding Corp. - VentureRadar
Website: http://www.mondobiotech.com. Mondobiotech is an unconventional drug discovery company dedicated to treating rare and neglected diseases, some of them chronic, many of …See details»
Alles zum Thema mondoBIOTECH im Überblick - Handelszeitung
Vom Klostergebäude aus will MondoBiotech die Welt der seltenen Krankheiten revolutionieren. Obwohl ein Start-up, wird Geld mit vollen Händen... Stefan LüscherSee details»
Press Release - 23andMe Media Center
Jan 28, 2009 · mondoBIOTECH is the Swiss open source biotech aiming to improve the health of patients affected by rare diseases. mondoBIOTECH currently has a product pipeline of more …See details»
Pierrel in negotiations for mondoBIOTECH merger - PharmaTimes
Mar 6, 2012 · Pierrel, the company based in Italy that provides contract research, manufacturing and other services to the pharmaceutical and life science industries worldwide, is in exclusive …See details»
MondoBiotech: Bettelmönche | BILANZ - Handelszeitung
Feb 25, 2011 · Vom Klostergebäude aus will MondoBiotech die Welt der seltenen Krankheiten revolutionieren. Obwohl ein Start-up, wird Geld mit vollen Händen ausgegeben – und via …See details»
mondoBIOTECH: The Swiss biotech BOUTIQUE - Wiley Online Library
Aug 25, 2005 · Summary This chapter contains sections titled: Introduction Product Platforms Interferon-γ + Genechip Bacteriophages Outlook for the CompanySee details»
Biogen Idec and mondoBIOTECH sign collaboration and licensing …
Sep 18, 2006 · Biogen Idec and mondoBIOTECH AG announced the signing of an exclusive collaboration and license agreement for Biogen Idec to develop, manufacture and …See details»
Biogen inks $37.5M licensing deal with MondoBiotech
Sep 13, 2006 · Biogen Idec is paying $7.5 million up front and up to $30 million in milestones for the right to develop a new therapy for pulmonary arterial hyperntension from MondoBiotech.See details»
Patents Assigned to mondoBIOTECH Laboratories AG
Sep 9, 2008 · Abstract: The present invention is directed to the use of the peptide compound D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol as a therapeutic agent for the prophylaxis …See details»